PSI Structural Biology Knowledgebase

PSI | Structural Biology Knowledgebase
Header Icons

Related Articles
Protein Folding and Misfolding: It's the Journey, Not the Destination
March 2015
CCR5 and HIV Infection
January 2015
HIV/AIDS: Pre-fusion Env Exposed
January 2015
HIV/AIDS: Slide to Enter
January 2015
Updating ModBase
January 2015
Power in Numbers
August 2014
Quorum Sensing: A Groovy New Component
August 2014
Bacterial CDI Toxins
June 2014
Immunity: One Antibody to Rule Them All
June 2014
Virology: A Bat Influenza Hemagglutinin
March 2014
Virology: Making Sensitive Magic
March 2014
Virology: Visualizing Cyanophage Assembly
March 2014
Virology: Zeroing in on HBV Egress
March 2014
March 2014
Cas4 Nuclease and Bacterial Immunity
February 2014
Microbial Pathogenesis: A GNAT from Pseudomonas
February 2014
Microbial Pathogenesis: Targeting Drug Resistance in Mycobacterium tuberculosis
February 2014
Microbiome: The Dynamics of Infection
September 2013
Membrane Proteome: A Funnel-like Viroporin
August 2013
Infectious Diseases: A Pathogen Ubiquitin Ligase
May 2013
Infectious Diseases: A Shared Syringe
May 2013
Infectious Diseases: Determining the Essential Structome
May 2013
Infectious Diseases: Targeting Meningitis
May 2013
NDM-1 and Antibiotics
May 2013
Bacterial Hemophores
January 2013
Microbial Pathogenesis: Computational Epitope Prediction
January 2013
Microbial Pathogenesis: Influenza Inhibitor Screen
January 2013
Microbial Pathogenesis: Measles Virus Attachment
January 2013
Microbial Pathogenesis: NEAT Iron
January 2013
Membrane Proteome: Sphingolipid Synthesis Selectivity
December 2012
A signal sensing switch
September 2012
Gauging needle structure
July 2012
Anthrax Stealth Siderophores
June 2012
A Pseudomonas L-serine dehydrogenase
May 2012
Pilus Assembly Protein TadZ
April 2012
Making Lipopolysaccharide
January 2012
Superbugs and Antibiotic Resistance
December 2011
A change to resistance
November 2011
An effective and cooperative dimer
November 2011
The Perils of Protein Secretion
November 2011
Bacterial Armor
October 2011
Breaking down the defenses
September 2011
Moving some metal
August 2011
Capsid assembly in motion
April 2011
Know thy enemy … structurally
October 2010
Treating sleeping sickness
May 2010
Bacterial spore kinase
April 2010
Hemolysin BL
January 2010
Unusual cell division
October 2009
Anthrax evasion tactics
September 2009
Toxin-antitoxin VapBC-5
September 2009
Antibiotic target
August 2009
July 2009
Tackling influenza
June 2009
You look familiar: the Type VI secretion system
June 2009
Unique SARS
April 2009
Anthrax stealth molecule
March 2009
A new class of bacterial E3 ubiquitination enzymes
January 2009
Antiviral evasion
October 2008
SARS connections
September 2008
SARS Coronavirus Nonstructural Protein 1
June 2008

Research Themes Infectious diseases

Antibiotic target

PSI-SGKB [doi:10.1038/fa_psisgkb.2009.33]
Featured Article - August 2009
Short description: An unusual reaction in the production of thymine offers hope for anti-tuberculosis drugs.Nature 458, 919-923 (2009)

Crystal structures of the FDTS–FAD–dUMP complex. a, Wild-type TmFDTS (PDB 1O26); b, S88A mutant (PDB 3G4A); c, S88C mutant (PDB 3G4C).

Several antibiotic drugs target the synthesis of the DNA base thymine by bacteria to prevent them replicating. These drugs aim to block classical thymidylate synthases, which add a methyl to the uracil of deoxyuridine monophosphate (dUMP) to produce deoxythymidine monophosphate (dTMP). But classical thymidylate synthases are present in humans as well prokaryotes, so attacking this enzyme risks potential side effects.

Recently, a new class of thymidylate synthases was discovered, called the flavin-dependent thymidylate synthases (FDTSs). They are encoded by a thyX gene, whereas the better studied version is encoded by thyA and TYMS genes. This group of enzymes is present mainly in prokaryotes and viruses and is not found in humans. In addition, they have no structural or sequence similarity to classical thymidylate synthases, and so could be a promising new drug target. Of particular interest is that they are found in several devastating pathogens, such a tuberculosis, and in agents of biological warfare.

Classical thymidylate synthases use a cysteine residue in their active site to activate the uracil ring of dUMP, and it has been suggested that FDTS might use a similar mechanism. Sequence analysis suggested that a conserved serine in the active site acts as the nucleophile.

Several structures of various FDTSs from different organisms indicated, however, that this serine was located 4 Å from the C6 position of dUMP – too far away for it be part of the catalytic mechanism. Koehn et al. mutated this serine to an inactive alanine and found that this alteration did not prevent thymidylate synthase activity. Thus, serine is not the catalytic nucleophile in the FDTS reaction.

To understand how this unusual enzyme works, Koehn et al. crystallized thymidylate synthase from Thermotoga maritima with the serine mutated either to alanine (S88A) or to cysteine (S88C) and compared their structures to the wild type. There was no covalent bond between the cysteine and dUMP in the latter crystal structure, despite previous reports of a bond between C6 of the uracil and the cysteine. It appears that this complex is not part of the pathway and instead forms an inhibitory complex.

To establish the nature of the FDTS-catalysed reaction, Koehn et al. followed the flow of hydrogens during the reaction by introducing hydrogen isotopes that could be tracked using mass spectroscopy and NMR spectroscopy. Their results indicate that an intermediate hydride (a proton and two electrons) is transferred from the reduced flavin cofactor directly to the uracil ring. The intermediate then isomerizes to form the product dTMP. Formation of such an intermediate has never been reported before for FDTSs, but it appears to be chemically feasible and stable in solution.

This elegant combination of crystallography and detailed mechanistic studies has revealed a new nucleotide methylation pathway that will be of great interest to biochemists wishing to design drugs to thwart bacterial replication.

Maria Hodges


  1. E. M. Koehn et al. An unusual mechanism of thymidylate biosynthesis in organisms containing the thyX gene.
    Nature. 458, 919-923 (2009), doi: 10.1038/nature07973.

Structural Biology Knowledgebase ISSN: 1758-1338
Funded by a grant from the National Institute of General Medical Sciences of the National Institutes of Health